glp-1 kidney outcomes news Renal effects of receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine GLP-1 receptor agonists' impact on
Description
Rather than flooding the bloodstream with insulin unnecessarily, GLP-1 helps the body release the right amount at the right time
N Engl J Med 2016;375: 311-22
An individual in the 24% federal tax bracket who uses HSA funds for semaglutide (starting at $149/month or $1,788 annually) avoids approximately $429 in federal taxes per year
And a little grace
[DOI] [PubMed] [Google Scholar] 529.Wild D, et al
